8 07, 2017 Chiara Pesenti et al. Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status Diatech Pharmacogenetics2017-09-14T09:58:04+02:00 Read More
28 06, 2017 Pierina Navarria et al., Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study Diatech Pharmacogenetics2017-11-21T16:09:45+01:00 Read More
28 06, 2017 Pierina Navarria et al., Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study Diatech Pharmacogenetics2017-11-21T15:56:09+01:00 Read More
16 06, 2017 Fabiana Pani et al., Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report. Oncology Letters Diatech Pharmacogenetics2017-08-24T15:02:16+02:00 Read More
15 06, 2017 Sara Mariani et al., Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene. British Journal of Cancer Diatech Pharmacogenetics2017-06-15T13:03:05+02:00 Read More
1 06, 2017 Andrea Imperatori et al., LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer Diatech Pharmacogenetics2017-11-02T12:15:31+01:00 Read More
5 05, 2017 Umberto Malapelle et al., Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens. Diatech Pharmacogenetics2017-05-05T14:46:57+02:00 Read More
30 03, 2017 Deborah Saraggi et al., Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver. Pathology – Research and Practice Diatech Admin2017-08-03T14:57:31+02:00 Read More
7 03, 2017 Andrea Imperatori et al., LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer. Lung Cancer Journal Diatech Pharmacogenetics2017-08-03T14:03:59+02:00 Read More
1 03, 2017 Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix. Diatech Pharmacogenetics2017-11-02T13:03:08+01:00 Read More
